Fennec Pharmaceuticals (FENC) Change in Cash (2010 - 2025)
Fennec Pharmaceuticals' (FENC) quarterly Change in Cash came in at $14.8 million in Q4 2025, up 208.44% YoY from $4.8 million in Q4 2024, and up 357.77% on a QoQ basis from $3.2 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Change in Cash (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Change in Cash data on file, last reported at $14.8 million in Q4 2025.
- Quarterly Change in Cash rose 208.44% year-over-year to $14.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.2 million (down 24.03% YoY) and the FY2025 annual result came in at $10.2 million, down 24.03% from the prior year.
- Change in Cash rose to $14.8 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $37.9 million in Q1 2024 to a low of -$13.7 million in Q4 2024.
- A 5-year average of $322200.0 and a median of -$3.1 million in 2021 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 804.22% in 2024, down 1673.1% in 2024.
- Tracing FENC's Change in Cash over 5 years: stood at -$3.2 million in 2021, then tumbled by 84.79% to -$6.0 million in 2022, then surged by 114.55% to $870000.0 in 2023, then slumped by 1673.1% to -$13.7 million in 2024, then surged by 208.44% to $14.8 million in 2025.
- The last three Change in Cash figures came in at $14.8 million (Q4 2025), $3.2 million (Q3 2025), and -$4.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.84 Mn |
| Sep 30, 2025 | 3.24 Mn |
| Jun 30, 2025 | -3.97 Mn |
| Mar 31, 2025 | -3.96 Mn |
| Dec 31, 2024 | -13.69 Mn |
| Sep 30, 2024 | -2.73 Mn |
| Jun 30, 2024 | -8.13 Mn |
| Mar 31, 2024 | 37.92 Mn |
| Dec 31, 2023 | 870,000.00 |
| Sep 30, 2023 | -2.56 Mn |
| Jun 30, 2023 | -3.43 Mn |
| Mar 31, 2023 | -5.38 Mn |
| Dec 31, 2022 | -5.98 Mn |
| Sep 30, 2022 | 14.84 Mn |
| Jun 30, 2022 | -3.34 Mn |
| Mar 31, 2022 | -2.84 Mn |
| Dec 31, 2021 | -3.24 Mn |
| Sep 30, 2021 | -2.96 Mn |
| Jun 30, 2021 | 542,000.00 |
| Mar 31, 2021 | -3.59 Mn |